Cadoz M, Denis F, Guerma T, Prince-David M, Diop Mar I
Pathol Biol (Paris). 1982 Jun;30(6 Pt 2):522-5.
Two series of patients suffering purulent meningitis were treated: one (137 patients) with amoxycillin (200 mg/kg/day) by 4 intramuscular injections each day, the other with ceftriaxone (163 patients)/42 mg/Kg/day IM by intramuscular injections each day in the first 23 patients and then only one injection by day in the 140 other patients. Bacteriologically the superiority of CFTRX appears the whole studied strains: MIC of CFTRX are four times lower than those of AMOX for pneumococci, ten times lower for H. influenzae, hundred time lower for meningococci. Amongst the add strains the percentage of resistance to AMOX reaches 64 and only 7 to CFTRX. Pharmacologically, after a same dose of 50mg/kg the peak concentrations in CSF has the same level: CFTRX: 6.8 micrograms/ml, AMOX: 6 micrograms/ml. CSF levels remain efficient for 2 hours with AMOX and for 24 hours with CFTRX. The therapeutic index (mean antibiotic concentration in CSF/mean MIC of the strains) is higher with CFTRX than with AMOX (X 4 for pneumococci, X 15 for H. influenzae, X 100 for meningococci). Clinical results are better with CFTRX than with AMOX in each of the aetiological groups except meningococcal meningitis but the only significative difference concerns pneumococcal meningitis. Clinical tolerance of the two treatments was good. However 2 neonates treated with CFTRX has a severe eczematous erythrodermia and 8 other patients treated with CFTRX had diarrhoea due to elimination of the sensitive flora.
一组(137例患者)使用阿莫西林(200mg/kg/天),每天分4次肌肉注射;另一组(163例患者)使用头孢曲松,前23例患者每天肌肉注射42mg/Kg/天,其余140例患者每天仅注射1次。从细菌学角度看,在所有研究菌株中,头孢曲松表现出优势:肺炎球菌对头孢曲松的最低抑菌浓度(MIC)比阿莫西林低四倍,流感嗜血杆菌低十倍,脑膜炎球菌低百倍。在附加菌株中,对阿莫西林耐药的百分比达到64%,而对头孢曲松耐药的仅为7%。在药理学方面,给予相同剂量50mg/kg后,脑脊液中的峰值浓度处于同一水平:头孢曲松为6.8微克/毫升,阿莫西林为6微克/毫升。阿莫西林的脑脊液水平在2小时内保持有效,而头孢曲松则为24小时。头孢曲松的治疗指数(脑脊液中平均抗生素浓度/菌株的平均MIC)高于阿莫西林(肺炎球菌为4倍,流感嗜血杆菌为15倍,脑膜炎球菌为100倍)。除脑膜炎球菌性脑膜炎外,在每个病因组中,头孢曲松的临床效果均优于阿莫西林,但唯一有显著差异的是肺炎球菌性脑膜炎。两种治疗方法的临床耐受性良好。然而,2例接受头孢曲松治疗的新生儿出现了严重的湿疹性红皮病,另有8例接受头孢曲松治疗的患者因敏感菌群被清除而出现腹泻。